Eukaryotic elongation factor 2 kinase inhibitor, A484954 inhibits perivascular sympathetic nerve stimulation-induced vasoconstriction in isolated renal artery

Eur J Pharmacol. 2022 Jul 5:926:175042. doi: 10.1016/j.ejphar.2022.175042. Epub 2022 May 19.

Abstract

Eukaryotic elongation factor 2 (eEF2) kinase (eEF2K) repressively regulates protein translation through phosphorylating eEF2. We previously showed that expression and activity of eEF2K are increased in isolated mesenteric arteries from spontaneously hypertensive rats (SHR) contributing to development of essential hypertension. Furthermore, we have recently shown that 7-Amino-1-cyclopropyl-3-ethyl-1,2,3,4-tetrahydro-2,4-dioxopyrido[2,3-d]pyrimidine-6-carboxamide (A484954), a selective eEF2K inhibitor, induces endothelium-dependent relaxation in isolated mesenteric arteries from SHR inducing an antihypertensive effect. In order to test the hypothesis that inhibition of eEF2K activity induces vasodilatation by suppressing sympathetic nerve activity, we examined the effects of A484954 on perivascular sympathetic nerve stimulation-induced contraction in isolated renal artery from normotensive and hypertensive rats. Electrodes were placed near the isolated renal arteries that were applied with transmural nerve stimulation (TNS). Then, contraction of the arteries was isometrically measured. A484954 inhibited TNS-induced contraction. The A484954-mediated inhibition of TNS-induced contraction was significantly prevented by NG-nitro-L-arginine methyl ester. In SHR isolated renal artery, TNS-induced contraction was enhanced compared with normotensive Wistar rats. Furthermore, A484954-mediated inhibition of TNS-induced contraction in SHR was enhanced compared with Wistar rats. In conclusion, this study demonstrates for the first time that A484954 inhibits perivascular sympathetic nerve stimulation-induced vasoconstriction at least in part perhaps through nitric oxide (NO) release from NO-operating nerve.

Keywords: Eukaryotic elongation factor 2 kinase; Hypertension; Nitric oxide; Sympathetic nerve.

MeSH terms

  • Animals
  • Elongation Factor 2 Kinase* / antagonists & inhibitors
  • Elongation Factor 2 Kinase* / metabolism
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / innervation
  • Endothelium, Vascular / metabolism
  • Hypertension / drug therapy
  • Hypertension / metabolism
  • Mesenteric Arteries / drug effects
  • Mesenteric Arteries / innervation
  • Mesenteric Arteries / metabolism
  • Nitric Oxide / metabolism
  • Phosphorylation
  • Protein Kinase Inhibitors* / pharmacology
  • Pyridines / pharmacology
  • Pyrimidines / pharmacology
  • Rats
  • Rats, Inbred SHR
  • Rats, Wistar
  • Renal Artery* / drug effects
  • Renal Artery* / innervation
  • Renal Artery* / metabolism
  • Vasoconstriction* / drug effects
  • Vasoconstriction* / physiology
  • Vasodilation / drug effects
  • Vasodilation / physiology
  • Vasomotor System* / drug effects
  • Vasomotor System* / metabolism

Substances

  • A-484954
  • Protein Kinase Inhibitors
  • Pyridines
  • Pyrimidines
  • Nitric Oxide
  • Eef2k protein, rat
  • Elongation Factor 2 Kinase